Novel role of lncRNAs regulatory network in papillary thyroid cancer

© 2024 The Authors..

Papillary thyroid cancer (PTC) is the most common endocrine malignancy. The incidence of PTC has increased annually worldwide. Thus, PTC diagnosis and treatment attract more attention. Noncoding RNAs (lncRNAs) play crucial roles in PTC progression and act as prognostic biomarkers. Moreover, microRNAs (miRNAs) and epithelial-mesenchymal transition (EMT)-associated proteins have potential biomarkers for diagnosing and treating PTC. However, the correlation of lncRNAs with miRNAs and EMT-associated proteins needs further clarification. The present review highlights the recent advances of lncRNAs in PTC. We significantly summarized the two molecular regulatory mechanisms in PTC progress, including lncRNAs-miRNAs-protein signaling axes and lncRNAs-EMT pathways. This review will help our understanding of the association between lncRNAs and PTC and may assist us in evaluating the prognosis for PTC patients. Taken together, targeting the lncRNAs regulatory network has promising applications in diagnosing and treating PTC.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Biochemistry and biophysics reports - 38(2024) vom: 30. März, Seite 101674

Sprache:

Englisch

Beteiligte Personen:

Su, Yuanhao [VerfasserIn]
Mei, Lin [VerfasserIn]
Jiang, Tiantian [VerfasserIn]
Wang, Zhidong [VerfasserIn]
Ji, Yuanyuan [VerfasserIn]

Links:

Volltext

Themen:

Diagnosis
EMT
Journal Article
LncRNAs
MiRNAs
Papillary thyroid cancer
Prognosis
Review

Anmerkungen:

Date Revised 06.03.2024

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.bbrep.2024.101674

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369299205